If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Pediatrix Medical Group (MD) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Pediatrix's (MD) second-quarter earnings benefit from stable patient volumes. Rising expenses act as a partial offset.
Pediatrix Medical Group, Inc. (NYSE:MD ) Q2 2024 Earnings Conference Call August 6, 2024 9:00 AM ET Company Participants Charles Lynch - SVP, Finance & Strategy Jim Swift - CEO Marc Richards - CFO Kasandra Rossi - SVP, Financial Reporting & Assistant Treasurer Conference Call Participants A.J. Rice - UBS Nur Robleh - Jefferies Benjamin Shaver - Deutsche Bank Kevin Fischbeck - Bank of America Operator Ladies and gentlemen, thank you for standing by.
Pediatrix Medical Group (MD) came out with quarterly earnings of $0.34 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.39 per share a year ago.
Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock?